Michael J. Rybak, PharmD, MPH, FCCP, BCPS
Associate Dean for Research
Professor of Pharmacy and Medicine
Director,
The Anti-Infective Research Laboratory
Eugene Applebaum College of Pharmacy and
Health Science
Wayne State University
259 Mack Ave
Detroit, Michigan 48201
Tel: 313 577-4376
Fax:313 577-8915
email: m.rybak@wayne.edu
Dr. Rybak received his Doctor of
Pharmacy degree from the College of Pharmacy and Masters of Publilc Health
from the School of Medicine at Wayne State University, Detroit Michigan.
He earned his Bachelor of Science Degree in Pharmacy from Northeastern
University in Boston, Massachusetts. He is currently, Associate Dean for
Research, Professor of Pharmacy Practice and Medicine and the Director,
Anti-Infective Research Laboratory at the Eugene Applebaum College of
Pharmacy and Health Sciences at Wayne State University. Dr. Rybak is also
clinical faculty and a member of the antimicrobial formulary committee at
the Detroit Medical Center.
Dr. Rybak is an established author and
lecturer in the area of antimicrobials. His most recent work has been in
the areas of community-associated methicillin-resistant MRSA, vancomycin-resistant
staphylococci, penicillin-resistant and tolerant-Streptococcus pneumoniae,
and pharmacodynamic assessments of antibiotics alone and in combination
using in vitro and clinical models of antibiotic resistance. Dr. Rybak
serves as the scientific editor for Infectious Diseases for the journal
Pharmacotherapy and serves as a reviewer and/or editorial panel member for
Antimicrobial Agents Chemotherapy, Journal of Antimicrobial Chemotherapy,
Clinical Infectious Diseases and the Journal of Infectious Diseases
Pharmacotherapy.
Dr. Rybak has received numerous
special awards, including the American College of Clinical Pharmacy
Infectious Diseases Fellowship Award, The Russell Miller Award for Sustain
Contributions to Literature of Clinical Pharmacy, Wayne State University's
Academic Achievement Award for Natural Sciences, American Society of
Health System Pharmacist's Research Foundation Award for Sustained
Contributions to the Literature and the Society of Infectious Diseases
Pharmacists Award of Impact Paper of the Year. In addition, he is a fellow
of the American College of Clinical Pharmacy and the Infectious Diseases
Society of America. Dr. Rybak is a founding member and Past-President of
the Society of Infectious Diseases Pharmacists. Dr. Rybak is board
certified as a pharmacotherapy specialist by the Board of Pharmaceutical
Specialists with added qualifications for Infectious Diseases
Pharmacotherapy. |